Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients (Q98184361)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

title

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

1 reference

1 reference

inferred from abstract

author name string

Hai-Xia Su

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Sheng Yao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Wen-Feng Zhao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Min-Jun Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Jia Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Wei-Juan Shang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Hang Xie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Chang-Qiang Ke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Hang-Chen Hu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Mei-Na Gao

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Kun-Qian Yu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Hong Liu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Jing-Shan Shen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Wei Tang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Lei-Ke Zhang

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Geng-Fu Xiao

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Li Ni

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Dao-Wen Wang

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Jian-Ping Zuo

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Hua-Liang Jiang

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Fang Bai

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Yan Wu

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Yang Ye

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

Ye-Chun Xu

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

9 August 2020

publication date

31 July 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

Acta Pharmacologica Sinica

9 August 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32737471%20AND%20SRC:MED&resulttype=core&format=json

Coronaviruses - drug discovery and therapeutic options.

9 August 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

SARS and MERS: recent insights into emerging coronaviruses

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

A pneumonia outbreak associated with a new coronavirus of probable bat origin

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

An interactive web-based dashboard to track COVID-19 in real time

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Design of wide-spectrum inhibitors targeting coronavirus main proteases

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Structure of Mpro from COVID-19 virus and discovery of its inhibitors

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Comparative Study on the Antivirus Activity of Shuang-Huang-Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Antiviral effect of forsythoside A from Forsythia suspensa (Thunb.) Vahl fruit against influenza A virus through reduction of viral M1 protein

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Antiviral effects of Shuanghuanglian injection powder against influenza A virus H5N1 in vitro and in vivo

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

A combination of representative compounds, metabolism platform and diagnostic extraction strategy for characterization of metabolites of Shuang-Huang-Lian oral liquid in vivo by ultra-performance liquid chromatography coupled with time-of-flight mas

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Optimization of Electrospray Ionization by Statistical Design of Experiments and Response Surface Methodology: Protein-Ligand Equilibrium Dissociation Constant Determinations

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Phasercrystallographic software

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Coot: model-building tools for molecular graphics

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

PHENIX: building new software for automated crystallographic structure determination

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Comment on The Ecstasy and Agony of Assay Interference Compounds

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus [...]

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Baicalin and its aglycone: a novel approach for treatment of metabolic disorders

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects

26 May 2021

1 reference

https://api.crossref.org/works/10.1038/S41401-020-0483-6

Upgrade of macromolecular crystallography beamline BL17U1 at SSRF

26 May 2021

1 reference

https://api.crossref.org/works/10.1038%2FS41401-020-0483-6